D+79
Today is 2022. 12. 02

Program at a glance

  • Home
  • Program
  • Program at a glance
Program at a Glance Download
Floor 3F 5F 6F
Room 1 2 3 4 Poster Hall
11:00~ Registration
12:00~12:50 Luncheon Symposium 1
[Daewoong]
Luncheon Symposium 2
[Chong Kun Dang]
Poster Viewing
12:50~14:20 Symposium 1

Optimal risk factor control in
patients with DM

Basic Research Workshop 1

Lipid metabolism & metabolic
disorders

Symposium 2

Novel risk factors &
intervention targets in
atherosclerosis

Symposium 3

NAFLD, metabolic dysfunction
& ASCVD

14:20~14:30 Coffee Break
14:30~15:30 Oral Presentation 1
(APSAVD Young Investigator Session)
15:30~17:00 Symposium 4

Update on coronary CT:
risk marker, monitoring tool
& future perspective

Basic Research Workshop 2

SMC plasticity in plaque stability

Symposium 5

Lipid as risk & target in
cerebrovascular disease

Floor 3F 5F 6F
Room 1 2 3 4 Poster Hall
07:00~07:30 Registration
08:00~09:00 Breakfast Symposium 1
[Celltrionpharm]
Breakfast Symposium 2
[Organon]
Poster Viewing
09:00~09:40 Plenary Lecture 1

From reading the genome for risk to rewriting it for cardiovascular health

09:40~09:45 Break
09:45~11:15 Symposium 6

Adipose tissue & atherosclerosis

Symposium 7

New regulators of dyslipidemia &
atherosclerosis

Symposium 8

High CV risk group: is it
properly defined?

Symposium 9

Update on non-
pharmacological control of
ASCVD risk

11:15~11:25 Coffee Break
11:25~11:30 Opening Address
11:30~12:00 Plenary Lecture 2 (APSAVD:Ding Lecture)

Recent developments in the treatment of familial hypercholesterolaemia
& other familial lipid disorders

12:00~12:50 Luncheon Symposium 3
[Organon]
Luncheon Symposium 4
[JW Pharmaceutical]
Luncheon Symposium 5
[Viatris]
Luncheon Symposium 6
[Boehringer Ingelheim/Lilly]
12:50~12:55 Break
12:55~13:35 Plenary Lecture 3

Senescence & vascular smooth muscle cell plasticity

13:35~15:05 Symposium 10

Debate on developing risk
grouping in Korea: current
status, comparison with foreign,
& solution

Food & Nutrition Workshop

Cardiometabolic disease &
customized nutrition management

Symposium 11

Inflammation in progression &
inhibition of atherosclerosis

Symposium 12
(EAS/APSAVD/JAS
Joint Symposium)

Dyslipidaemia

15:05~15:15 Coffee Break
15:15~16:15 Oral Presentation 2 Oral Presentation 3 2022 KSoLA Awards for Scientific Excellence & Young Investigator

Scientific Excellence Award Lecture

Moderated
Poster 1,2,5
(Kor / Eng)
16:15~17:45 Symposium 13

Debate on new Korean guidelines on dyslipidemia: treatment

Publication Committee Session Symposium 14
(JAS/KSoLA Joint Symposium)

Impact of aging of vascular cells on atherosclerosis & its protection

Symposium 15
(APSAVD Joint Symposium)

COVID-19 & cardiovascular risk

Poster Viewing
Floor 3F 5F 6F
Room 1 2 3 4 Poster Hall
07:00~07:30 Registration
08:00~09:00 Breakfast Symposium 3
[Yuhan]
Breakfast Symposium 4
[JW Pharmaceutical]
Poster Viewing
09:00~09:40 Plenary Lecture 4

Effect of alirocumab in subjects with likely familial hypercholesterolemia or type III hyperlipidemia: analyses from the ODYSSEY outcomes study

09:40~09:45 Break
09:45~11:15 Symposium 16

Current issues in severe
dyslipidemia

Symposium 17

Emerging targets & drug
platforms in dyslipidemia &
atherosclerosis

Symposium 18

Role & unsolved issues of novel
lipid-modifying agents

Symposium 19

Current nutritional knowledge
in cardiometabolic health

11:15~11:25 Coffee Break
11:25~12:05 Plenary Lecture 5

Best approach to cardio & cerebrovascular health in older people

12:05~12:55 Luncheon Symposium 7
[Inno.N]
Luncheon Symposium 8
[Hanmi]
Luncheon Symposium 9
[Amgen]
Luncheon Symposium 10
[Sanofi]
12:55~13:00 Break
13:00~13:30 Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Up close & personal with vascular diseases: the role of precision medicine

13:30~13:35 Break
13:35~14:35 Oral Presentation 4 Oral Presentation 5 Moderated
Poster 3,4
(Kor / Eng)
14:35~14:45 Coffee Break Poster viewing
14:45~16:15 Symposium 20

How will new technologies
change our research & patient
care in ASCVD?

Symposium 21

New concepts in vascular biology

Symposium 22
(TSLA/KSoLA Joint Symposium)

Sex difference in dyslipidemia & atherosclerosis

Symposium 23
(APSAVD Joint Symposium)

Update on antibodies & siRNA against PCSK9

16:15~ Closing Ceremony
Sponsored by